Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Solanich

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Arthritis Care & Research|April 30, 2019
Comparison of the Birmingham Vasculitis Activity Score and the Five-Factor Score to Assess Survival in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Study of 550 Patients From Spain (REVAS Registry)Roser Solans-Laqué, Monica Rodriguez-Carballeira, Juan Jose Rios-Blanco, et al.
Medicine|February 23, 2017
Clinical characteristics and outcome of Spanish patients with ANCA-associated vasculitides: Impact of the vasculitis type, ANCA specificity, and treatment on mortality and morbidityRoser Solans-Laqué, Guadalupe Fraile, Monica Rodriguez-Carballeira, et al.
Frontiers in Immunology|August 9, 2021
Genetic Screening for <i>TLR7</i> Variants in Young and Previously Healthy Men With Severe COVID-19Xavier Solanich, Gardenia Vargas-Parra, Caspar I van der Made, et al.
Journal of Clinical Apheresis|March 29, 2021
Incidence, diagnosis, and outcome of immune-mediated thrombotic thrombocytopenic purpura: A nationwide survey by the Spanish registry of thrombotic thrombocytopenic purpuraCristina Pascual-Izquierdo, Julio Del Rio-Garma, Javier de la Rubia, et al.
Journal of Clinical Immunology|September 27, 2021
Pre-existing Autoantibodies Neutralizing High Concentrations of Type I Interferons in Almost 10% of COVID-19 Patients Admitted to Intensive Care in BarcelonaXavier Solanich, Raúl Rigo-Bonnin, Victor-David Gumucio, et al.
Frontiers in Immunology|November 5, 2019
Expanding the Clinical and Genetic Spectra of Primary Immunodeficiency-Related Disorders With Clinical Exome Sequencing: Expected and Unexpected FindingsFrancesc Rudilla, Clara Franco-Jarava, Mónica Martínez-Gallo, et al.
Frontiers in Immunology|October 31, 2024
The impact of immune dysregulation on the risk of malignancy in common variable immunodeficiency: insights from a multicenter studyMarta Dafne Cabañero-Navalon, Victor Garcia-Bustos, Héctor Balastegui-Martin, et al.
Frontiers in Immunology|August 7, 2025
Real-world patterns of immunoglobulin replacement therapy for infection prevention in common variable immunodeficiency: a multicenter nationwide studyPedro Moral Moral, Victor Garcia-Bustos, Héctor Balastegui-Martin, et al.
Frontiers in Immunology|November 17, 2022
Current clinical spectrum of common variable immunodeficiency in Spain: The multicentric nationwide GTEM-SEMI-CVID registryMarta Dafne Cabañero-Navalon, Victor Garcia-Bustos, Maria Nuñez-Beltran, et al.
European Journal of Immunology|October 6, 2023
Single-cell multi-omics analysis of COVID-19 patients with pre-existing autoimmune diseases shows aberrant immune responses to infectionAnis Barmada, Louis-François Handfield, Gerard Godoy-Tena, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Arthritis Care & Research|April 30, 2019
Comparison of the Birmingham Vasculitis Activity Score and the Five-Factor Score to Assess Survival in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Study of 550 Patients From Spain (REVAS Registry)Roser Solans-Laqué, Monica Rodriguez-Carballeira, Juan Jose Rios-Blanco, et al.
Medicine|February 23, 2017
Clinical characteristics and outcome of Spanish patients with ANCA-associated vasculitides: Impact of the vasculitis type, ANCA specificity, and treatment on mortality and morbidityRoser Solans-Laqué, Guadalupe Fraile, Monica Rodriguez-Carballeira, et al.
Frontiers in Immunology|August 9, 2021
Genetic Screening for <i>TLR7</i> Variants in Young and Previously Healthy Men With Severe COVID-19Xavier Solanich, Gardenia Vargas-Parra, Caspar I van der Made, et al.
Journal of Clinical Apheresis|March 29, 2021
Incidence, diagnosis, and outcome of immune-mediated thrombotic thrombocytopenic purpura: A nationwide survey by the Spanish registry of thrombotic thrombocytopenic purpuraCristina Pascual-Izquierdo, Julio Del Rio-Garma, Javier de la Rubia, et al.
Journal of Clinical Immunology|September 27, 2021
Pre-existing Autoantibodies Neutralizing High Concentrations of Type I Interferons in Almost 10% of COVID-19 Patients Admitted to Intensive Care in BarcelonaXavier Solanich, Raúl Rigo-Bonnin, Victor-David Gumucio, et al.
Frontiers in Immunology|November 5, 2019
Expanding the Clinical and Genetic Spectra of Primary Immunodeficiency-Related Disorders With Clinical Exome Sequencing: Expected and Unexpected FindingsFrancesc Rudilla, Clara Franco-Jarava, Mónica Martínez-Gallo, et al.
Frontiers in Immunology|October 31, 2024
The impact of immune dysregulation on the risk of malignancy in common variable immunodeficiency: insights from a multicenter studyMarta Dafne Cabañero-Navalon, Victor Garcia-Bustos, Héctor Balastegui-Martin, et al.
Frontiers in Immunology|August 7, 2025
Real-world patterns of immunoglobulin replacement therapy for infection prevention in common variable immunodeficiency: a multicenter nationwide studyPedro Moral Moral, Victor Garcia-Bustos, Héctor Balastegui-Martin, et al.
Frontiers in Immunology|November 17, 2022
Current clinical spectrum of common variable immunodeficiency in Spain: The multicentric nationwide GTEM-SEMI-CVID registryMarta Dafne Cabañero-Navalon, Victor Garcia-Bustos, Maria Nuñez-Beltran, et al.
European Journal of Immunology|October 6, 2023
Single-cell multi-omics analysis of COVID-19 patients with pre-existing autoimmune diseases shows aberrant immune responses to infectionAnis Barmada, Louis-François Handfield, Gerard Godoy-Tena, et al.
Pageof 5